Pages that link to "Q58291953"
Jump to navigation
Jump to search
The following pages link to Predictors of Virological Success and Ensuing Failure in HIV-Positive Patients Starting Highly Active Antiretroviral Therapy in Europe (Q58291953):
Displaying 50 items.
- Therapeutic drug monitoring of antiretrovirals for people with HIV (Q24239932) (← links)
- Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy (Q24798930) (← links)
- AIDS-defining illnesses among patients with HIV in Singapore, 1985 to 2001: results from the Singapore HIV Observational Cohort Study (SHOCS) (Q24802044) (← links)
- Viral load responses to HAART is an independent predictor of a new AIDS event in late stage HIV infected patients: prospective cohort study (Q24814489) (← links)
- The epidemiological impact of antiretroviral use predicted by mathematical models: a review. (Q24814633) (← links)
- Better quality of life with neuropsychological improvement on HAART. (Q25256813) (← links)
- Adherence to antiretroviral therapy in adolescents living with HIV: systematic review and meta-analysis (Q27024379) (← links)
- Long-term efavirenz autoinduction and its effect on plasma exposure in HIV patients (Q28294491) (← links)
- Role of HIV infection duration and CD4 cell level at initiation of combination anti-retroviral therapy on risk of failure (Q28533767) (← links)
- Factors Associated with the Development of Drug Resistance Mutations in HIV-1 Infected Children Failing Protease Inhibitor-Based Antiretroviral Therapy in South Africa (Q28546698) (← links)
- Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean (Q28647212) (← links)
- The role of observational data in monitoring trends in antiretroviral treatment and HIV disease stage: results from the Australian HIV observational database (Q30771406) (← links)
- Utility of CD4 cell counts for early prediction of virological failure during antiretroviral therapy in a resource-limited setting (Q33349204) (← links)
- Magnitude and determinants of nonadherence and nonreadiness to highly active antiretroviral therapy among people living with HIV/AIDS in Northwest Ethiopia: a cross-sectional study (Q33753410) (← links)
- Comparative efficacy versus effectiveness of initial antiretroviral therapy in clinical trials versus routine care (Q33766361) (← links)
- Identification of novel HLA-A2-restricted human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte epitopes predicted by the HLA-A2 supertype peptide-binding motif (Q33836117) (← links)
- Outcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the U.S. Military HIV Natural History Study (Q33951598) (← links)
- Decline in the AIDS and death rates in the EuroSIDA study: an observational study (Q33967061) (← links)
- HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study (Q34370880) (← links)
- Virologic and Immunologic Response to Highly Active Antiretroviral Therapy (Q34537487) (← links)
- Goals and milestones during treatment of HIV-1 infection with antiretroviral therapy: a pathogenesis-based perspective (Q34699524) (← links)
- Could widespread use of combination antiretroviral therapy eradicate HIV epidemics? (Q34768657) (← links)
- New methods for the detection of HIV. (Q34875935) (← links)
- HIV disease and advanced age: an increasing therapeutic challenge (Q34967154) (← links)
- Changes in first-line cART regimens and short-term clinical outcome between 1996 and 2010 in The Netherlands (Q35010207) (← links)
- Findings from the first national clinical audit of treatment for people with HIV. (Q35048345) (← links)
- Elevated CD8 counts during HAART are associated with HIV virologic treatment failure. (Q35213754) (← links)
- The cost-effectiveness of counseling strategies to improve adherence to highly active antiretroviral therapy among men who have sex with men (Q35624701) (← links)
- Risk of Severe Non AIDS Events Is Increased among Patients Unable to Increase their CD4 T-Cell Counts >200 /μl Despite Effective HAART (Q35645143) (← links)
- Update on the Virologic and Immunologic Response to Highly Active Antiretroviral Therapy (Q35841783) (← links)
- Pharmacologic perspectives for once-daily antiretroviral therapy (Q35915916) (← links)
- Elevated CD8 T-cell counts and virological failure in HIV-infected patients after combination antiretroviral therapy (Q36100991) (← links)
- Cost-effectiveness of HIV screening in patients older than 55 years of age. (Q36191220) (← links)
- The ABCs of Trait Anger, Psychological Distress, and Disease Severity in HIV. (Q36215709) (← links)
- Updated clinical pharmacologic considerations for HIV-1 protease inhibitors (Q36223724) (← links)
- Bacterial infections in adult HIV-infected patients (Q36281588) (← links)
- Tipranavir: a protease inhibitor for multi-drug resistant HIV-1. (Q36349653) (← links)
- Patients' demographic and clinical characteristics and level of care associated with lost to follow-up and mortality in adult patients on first-line ART in Nigerian hospitals (Q36386792) (← links)
- Risk factors for short-term virologic outcomes among HIV-infected patients undergoing regimen switch of combination antiretroviral therapy (Q36419475) (← links)
- Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort (Q36487415) (← links)
- Persistent HIV Viremia: Description of a Cohort of HIV Infected Individuals with ART Failure in Puerto Rico (Q36512999) (← links)
- Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection (Q36618299) (← links)
- Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection. (Q36623603) (← links)
- Predictors of antiretroviral treatment failure in an urban HIV clinic (Q36628011) (← links)
- Antiretroviral treatment regimen outcomes among HIV-infected prisoners. (Q36692794) (← links)
- Impact of age on markers of HIV-1 disease (Q36763762) (← links)
- R57K polymorphism in the human immunodeficiency virus type 1 protease as predictor of early virological failure in a cohort of antiretroviral-naive patients treated mostly with a nelfinavir-containing regimen (Q36880577) (← links)
- Bimodal virological response to antiretroviral therapy for HIV infection: an application using a mixture model with left censoring (Q36933327) (← links)
- Effect of age and HAART regimen on clinical response in an urban cohort of HIV-infected individuals (Q37003774) (← links)
- Antiretroviral therapy : optimal sequencing of therapy to avoid resistance (Q37032556) (← links)